Current distribution and conservation of Najas tenuissima (Hydrocharitaceae)

Non peer reviewe

Intensity-dependent reflectance modulation of femtosecond laser pulses in GaAs nanocylinders with magnetic resonances

Abstract We experimentally demonstrate modulation of reflectance in periodic arrays of subwavelength gallium arsenide nanocylinders with Mie-type resonances due to absorption saturation and changes in the refractive index of the semiconductor material of metasurface. The intensity-dependent reflectance modulation of up to 30% in the vicinity of the magnetic dipole resonance at a low laser fluence below 200 μ J/cm 2 is shown by I-scan measurements

EPMA-World Congress 2015: Bonn, Germany. 3-5 September 2015

Table of contents A1 Predictive and prognostic biomarker panel for targeted application of radioembolisation improving individual outcomes in hepatocellular carcinoma Jella-Andrea Abraham, Olga Golubnitschaja A2 Integrated market access approach amplifying value of “Rx-CDx” Ildar Akhmetov A3 Disaster response: an opportunity to improve global healthcare Russell J. Andrews, Leonidas Quintana A4 USA PPPM: proscriptive, profligate, profiteering medicine-good for 1 % wealthy, not for 99 % unhealthy Russell J. Andrews A5 The role of IDO in a murine model of gingivitis: predictive and therapeutic potentials Babak Baban, Jun Yao Liu, Xu Qin, Tailing Wang, Mahmood S. Mozaffari A6 Specific diets for personalised treatment of diabetes type 2 Viktoriia V. Bati, Tamara V. Meleshko, Olga B. Levchuk, Nadiya V. Boyko A7 Towards personalized physiotherapeutic approach Joanna Bauer, Ewa Boerner, Halina Podbielska A8 Cells, animal, SHIME and in silico models for detection and verification of specific biomarkers of non-communicable chronic diseases Alojz Bomba, Viktor O. Petrov, Volodymyr G. Drobnych, Rostyslav V. Bubnov, Oksana M. Bykova, Nadiya V. Boyko A9 INTERACT-chronic care model: Self-treatment by patients with decision support e-Health solution Hans-Peter Brunner-La Rocca, Lutz Fleischhacker, Olga Golubnitschaja, Frank Heemskerk, Thomas Helms, Tiny Jaarsma, Judita Kinkorova, Jan Ramaekers, Peter Ruff, Ivana Schnur, Emilio Vanoli, Jose Verdu A10 PPPM in cardiovascular medicine in 2015 Hans-Peter Brunner-La Rocca A11 Magnetic resonance imaging of nanoparticles in mice, potential for theranostic and contrast media development – pilot results Rostyslav V. Bubnov, Sergiy A. Grabovetskyi, Olena M. Mykhalchenko, Natalia O. Tymoshok, Oleksandr B. Shcherbakov, Igor P. Semeniv, Mykola Y. Spivak A12 Ultrasound diagnosis for diabetic neuropathy - comparative study Rostyslav V. Bubnov, Tetyana V. Ostapenko A13 Ultrasound for stratification patients with diabetic foot ulcers for prevention and personalized treatment - pilot results Rostyslav V. Bubnov, Nazarii M. Kobyliak, Nadiya M. Zholobak, Mykola Ya. Spivak A14 Project ImaGenX – designing and executing a questionnaire on environment and lifestyle risk of breast cancer John Paul Cauchi A15 Genomics – a new structural brand of predictive, preventive and personalized medicine or the new driver as well? Dmitrii Cherepakhin, Marina Bakay, Artem Borovikov, Sergey Suchkov A16 Survey of questionnaires for evaluation of the quality of life in various medical fields Barbara Cieślik, Agnieszka Migasiewicz, Maria-Luiza Podbielska, Markus Pelleter, Agnieszka Giemza, Halina Podbielska A17 Personalized molecular treatment for muscular dystrophies Sebahattin Cirak A18 Secondary mutations in circulating tumour DNA for acquired drug resistance in patients with advanced ALK + NSCLC Marzia Del Re, Paola Bordi, Valentina Citi, Marta Palombi, Carmine Pinto, Marcello Tiseo, Romano Danesi A19 Recombinant species-specific FcεRI alpha proteins for diagnosis of IgE-mediated allergies in dogs, cats and horses Lukas Einhorn, Judit Fazekas, Martina Muhr, Alexandra Schoos, Lucia Panakova, Ina Herrmann, Krisztina Manzano-Szalai, Kumiko Oida, Edda Fiebiger, Josef Singer, Erika Jensen-Jarolim A20 Global methodology for developmental neurotoxicity testing in humans and animals early and chronically exposed to chemical contaminants Arpiné A. Elnar, Nadia Ouamara, Nadiya Boyko, Xavier Coumoul, Jean-Philippe Antignac, Bruno Le Bizec, Gauthier Eppe, Jenny Renaut, Torsten Bonn, Cédric Guignard, Margherita Ferrante, Maria Liusa Chiusano, Salvatore Cuzzocrea, Gerard O'Keeffe, John Cryan, Michelle Bisson, Amina Barakat, Ihsane Hmamouchi, Nasser Zawia, Anumantha Kanthasamy, Glen E. Kisby, Rui Alves, Oscar Villacañas Pérez, Kim Burgard, Peter Spencer, Norbert Bomba, Martin Haranta, Nina Zaitseva, Irina May, Stéphanie Grojean, Mathilde Body-Malapel, Florencia Harari, Raul Harari, Kristina Yeghiazaryan, Olga Golubnitschaja, Vittorio Calabrese, Christophe Nemos, Rachid Soulimani A21 Mental indicators at young people with attributes hypertension and pre-hypertension Maria E. Evsevyeva, Elena A. Mishenko, Zurida V. Kumukova, Evgeniy V. Chudnovsky, Tatyana A. Smirnova A22 On the approaches to the early diagnosis of stress-induced hypertension in young employees of State law enforcement agencies Maria E. Evsevyeva, Ludmila V. Ivanova, Michail V. Eremin, Maria V. Rostovtseva A23 Сentral aortic pressure and indexes of augmentation in young persons in view of risk factors Maria E. Evsevyeva, Michail V. Eremin, Vladimir I. Koshel, Oksana V. Sergeeva, Nadesgda M. Konovalova A24 Breast cancer prediction and prevention: Are reliable biomarkers in horizon? Shantanu Girotra, Olga Golubnitschaja A25 Flammer Syndrome and potential formation of pre-metastatic niches: A multi-centred study on phenotyping, patient stratification, prediction and potential prevention of aggressive breast cancer and metastatic disease Olga Golubnitschaja, Manuel Debald, Walther Kuhn, Kristina Yeghiazaryan, Rostyslav V. Bubnov, Vadym M. Goncharenko, Ulyana Lushchyk, Godfrey Grech, Katarzyna Konieczka A26 Innovative tools for prenatal diagnostics and monitoring: improving individual pregnancy outcomes and health-economy in EU Olga Golubnitschaja, Jan Jaap Erwich, Vincenzo Costigliola, Kristina Yeghiazaryan, Ulrich Gembruch A27 Immunohistochemical assessment of APUD cells in endometriosis Vadym M. Goncharenko, Vasyl O. Beniuk, Olga V. Kalenska, Rostyslav V. Bubnov A28 Updating personalized management algorithm of endometrial hyperplasia in pre-menopause women Vadym M. Goncharenko, Vasyl O. Beniuk, Rostyslav V. Bubnov, Olga Melnychuk A29 The personified treatment approach of polimorbid patients with periodontal inflammatory diseases Irina A. Gorbacheva, Lyudmila Y. Orekhova, Vadim V. Tachalov A30 Ukrainian experience in hybrid war – the challenge to update algorithms for personalized care and early prevention of different military injuries Olena I. Grechanyk, Rizvan Ya. Abdullaiev, Rostyslav V. Bubnov A31 Tear fluid biomarkers: a comparison of tear fluid sampling and storage protocols Suzanne Hagan, Eilidh Martin, Ian Pearce, Katherine Oliver A32 The correlation of dietary habits with gingival problems during menstruation Cenk Haytac, Fariz Salimov, Servin Yoksul, Anatoly A. Kunin, Natalia S. Moiseeva A33 Genomic medicine in a contemporary Spanish population of prostate cancer: our experience Bernardo Herrera-Imbroda, Sergio del Río-González, Maria Fernanda Lara, Antonia Angulo, Francisco Javier Machuca Santa-Cruz A34 Challenges, opportunities and collaborations for personalized medicine applicability in uro-oncological disease Bernardo Herrera-Imbroda, Sergio del Río-González, Maria Fernanda Lara A35 Metabolic hallmarks of cancer as targets for a personalized therapy John Ionescu A36 Influence of genetic polymorphism as a predictor of the development of periodontal disease in patients with gastric ulcer and 12 duodenal ulcer Alfiya Z. Isamulaeva, Anatoly A. Kunin, Shamil Sh. Magomedov, Aida I. Isamulaeva A37 Challenges in diabetic macular edema Tatjana Josifova A38 Overview of the EPMA strategies in laboratory medicine relevant for PPPM Marko Kapalla, Juraj Kubáň, Olga Golubnitschaja, Vincenzo Costigliola A39 EPMA initiative for effective organization of medical travel: European concepts and criteria Vincenzo Costigliola, Marko Kapalla, Juraj Kubáň, Olga Golubnitschaja A40 Design and innovation in e-textiles: implications for PPPM Anthony Kent, Tom Fisher, Tilak Dias A41 Biobank in Pilsen as a member of national node BBMRI_CZ Judita Kinkorová, Ondřej Topolčan A42 Big data in personalized medicine: hype and hope Matthias Kohl A43 The 3P approach as the platform of the European Dentistry Department (DPPPD) Anatoly A. Kunin, Natalia S. Moiseeva A44 The endometrium cytokine patterns for predictive diagnosis of proliferation severity and cancer prevention Andrii I. Kurchenko, Vasyl A. Beniuk, Vadym M. Goncharenko, Rostyslav V. Bubnov, Nadiya V. Boyko, Andriy M. Strokan A45 A monocyte-based in-vitro system for testing individual responses to the implanted material: future for personalized implant construction Julia Kzhyshkowska, Alexandru Gudima, Ksenia S. Stankevich, Victor D. Filimonov4, Harald Klüter, Evgeniya M. Mamontova, Sergei I. Tverdokhlebov A46 Prediction and prevention of adverse health effects by meteorological factors: Biomarker patterns and creation of a device for self-monitoring and integrated care Ulyana B. Lushchyk, Viktor V. Novytskyy, Igor P. Babii, Nadiya G. Lushchyk, Lyudmyla S. Riabets, Ivanna I. Legka A47 Targeting "disease signatures" towards personalized healthcare Mira Marcus-Kalish, Alexis Mitelpunkt, Tal Galili, Neta Shachar, Yoav Benjamini A48 Influence of the skin imperfection on the personal quality of life and possible tools for objective diagnosis Agnieszka Migasiewicz, Markus Pelleter, Joanna Bauer, Ewelina Dereń, Halina Podbielska A49 The new direction in caries prevention based on the ultrastructure of dental hard tissues and filling materials Natalia S. Moiseeva, Anatoly A. Kunin, Dmitry A. Kunin A50 The use of LED radiation in prevention of dental diseases Natalia S. Moiseeva, Yury A. Ippolitov, Dmitry A. Kunin, Alexei N. Morozov, Natalia V. Chirkova, Nakhid T. Aliev A51 Status of endothelial progenitor cells in diabetic nephropathy: predictive and preventive potentials Mahmood S. Mozaffari, Jun Yao Liu, Babak Baban A52 The status of glucocorticoid-induced leucine zipper protein in salivary gland in Sjögren’s syndrome: predictive and personalized treatment potentials Mahmood S. Mozaffari, Jun Yao Liu, Rafik Abdelsayed, Xing-Ming Shi, Babak Baban A53 Maximal aerobic capacity - important quality marker of health Jaroslav Novák, Milan Štork, Václav Zeman A54 The EMPOWER project: laboratory medicine and Horizon 2020 Wytze P. Oosterhuis, Elvar Theodorsson A55 Personality profile manifestations in patient’s attitude to oral care and adherence to doctor’s prescriptions Lyudmila Y. Orekhova, Tatyana V. Kudryavtseva, Elena R. Isaeva, Vadim V. Tachalov, Ekaterina S. Loboda A56 Results of an European survey on personalized medicine addressed to directions of laboratory medicine Mario Pazzagli, Francesca Malentacchi, Irene Mancini, Ivan Brandslund, Pieter Vermeersch, Matthias Schwab, Janja Marc, Ron H.N. van Schaik, Gerard Siest, Elvar Theodorsson, Chiara Di Resta A57 MCI or early dementia predictive speech based diagnosis techniques Matus Pleva, Jozef Juhar A58 Personalized speech based mobile application for eHealth Matus Pleva, Jozef Juhar A59 Circulating tumor cell-free DNA as the biomarker in the management of cancer patients Jiří Polívka jr., Filip Janků, Martin Pešta, Jan Doležal, Milena Králíčková, Jiří Polívka A60 Complex stroke care – educational programme in Stroke Centre University Hospital Plzen Jiří Polívka, Alena Lukešová, Nina Müllerová, Petr Ševčík, Vladimír Rohan A61 Sleep apnea and sleep fragmentation contribute to brain aging Kneginja Richter, Lence Miloseva, Günter Niklewski A62 Personalised approach for sleep disturbances in shift workers Kneginja Richter, Jens Acker, Guenter Niklewski A63 Medical travel and innovative PPPM clusters: new concept of integration Olga Safonicheva, Vincenzo Costigliola A64 Medical travel and women health Olga Safonicheva A65 Continuity of generations in the training of specialists in the field of reconstructive microsurgery Maxim Sautin, Janna Sinelnikova, Sergey Suchkov A66 Telemonitoring of stroke patients – empirical evidence of individual risk management results from an observational study in Germany Songül Secer, Stephan von Bandemer A67 Women’s increasing breast cancer risk with n-6 fatty acid intake explained by estrogen-fatty acid interactive effect on DNA damage: implications for gender-specific nutrition within personalized medicine Niva Shapira A68 Cytobacterioscopy of the gingival crevicular fluid as a method for preventive diagnosis of periodontal diseases Aleksandr Shcherbakov, Anatoly A. Kunin, Natalia S. Moiseeva A69 Use of specially treated composites in dentistry to avoid violations of aesthetics Bogdan R. Shumilovich, Zhanna Lipkind, Yulia Vorobieva, Dmitry A. Kunin, Anastasiia V. Sudareva A70 National eHealth system – platform for preventive, predictive and personalized diabetes care Ivica Smokovski, Tatjana Milenkovic A72 The common energy levels of Prof. Szent-Györgyi, the intrinsic chemistry of melanin, and the muscle physiopathology. Implications in the context of Preventive, Predictive, and Personalized Medicine Arturo Solís-Herrera, María del Carmen Arias-Esparza, Sergey Suchkov A73 Plurality and individuality of hepatocellular carcinoma: PPPM perspectives Krishna Chander Sridhar, Olga Golubnitschaja A74 Strategic aspects of higher medical education reforms to secure newer educational platforms for getting biopharma professionals matures Maria Studneva, Sihong Song, James Creeden, Мark Мandrik, Sergey Suchkov A75 Overview of the strategies and activities of the European Federation of Clinical Chemistry and Laboratory Medicine, (EFLM) Elvar Theodorsson, EFLM A76 New spectroscopic techniques for point of care label free diagnostics Syed A. M. Tofail A77 Tumor markers for personalized medicine and oncology - the role of Laboratory Medicine Ondřej Topolčan, Judita Kinkorová, Ondřej Fiala, Marie Karlíková, Šárka Svobodová, Radek Kučera, Radka Fuchsová, Vladislav Třeška, Václav Šimánek, Ladislav Pecen, Jan Šoupal, Štěpán Svačina2 A78 Modern medical terminology (MMT) as a driver of the global educational reforms Evgeniya Tretyak, Maria Studneva, Sergey Suchkov A79 Juvenile hypertension; the relevance of novel predictive, preventive and personalized assessment of its determinants Francesca M. Trovato, G. Fabio Martines, Daniela Brischetto, Daniela Catalano, Giuseppe Musumeci, Guglielmo M. Trovato A80 Proteomarkers Biotech George Th. Tsangaris, Athanasios K. Anagnostopoulos A81 Proteomics and mass spectrometry based non-invasive prenatal testing of fetal health and pregnancy complications George Th. Tsangaris, Athanasios K. Anagnostopoulos A82 Integrated Ecosystem for an Integrated Care model for Heart Failure (HF) patients including related comorbidities (ZENITH) José Verdú, German Gutiérrez, Jordi Rovira, Marta Martinez, Lutz Fleischhacker, Donna Green, Arthur Garson, Elena Tamburini, Stefano Cuomo, Juan Martinez-Leon, Teresa Abrisqueta, Hans-Peter Brunner-La Rocca, Tiny Jaarsma, Teresa Arredondo, Cecilia Vera, Giuseppe Fico, Olga Golubnitschaja, Fernando Arribas, Martina Onderco, Isabel Vara, on behalf of ZENITH consortium A83 Predictive, preventive and personalized medicine in diabetes onset and complication (MOSAIC project) José Verdú, Francesco Sambo, Barbara Di Camillo, Claudio Cobelli, Andrea Facchinetti, Giuseppe Fico, Riccardo Bellazzi, Lucia Sacchi, Arianna Dagliati, Daniele Segnani, Valentina Tibollo, Manuel Ottaviano, Rafael Gabriel, Leif Groop, Jacqueline Postma, Antonio Martinez, Liisa Hakaste, Tiinamaija Tuomi, Konstantia Zarkogianni, on behalf of MOSAIC consortium A84 Possibilities for personalized therapy of diabetes using in vitro screening of insulin and oral hypoglycemic agents Igor Volchek, Nina Pototskaya, Andrey Petrov A85 The innovative technology for personalized therapy of human diseases based on in vitro drug screening Igor Volchek, Nadezhda Pototskaya, Andrey Petrov A86 Bone destruction and temporomandibular joint: predictive markers, pathogenetic aspects and quality of life Ülle Voog-Oras, Oksana Jagur, Edvitar Leibur, Priit Niibo, Triin Jagomägi, Minh Son Nguyen, Chris Pruunsild, Dagmar Piikov, Mare Saag A87 Sub-optimal health management – global vision for concepts in medical travel Wei Wang A88 Sub-optimal health management: synergic PPPM-TCAM approach Wei Wang A89 Innovative technologies for minimal invasive diagnostics Andreas Weinhäusel, Walter Pulverer, Matthias Wielscher, Manuela Hofner, Christa Noehammer, Regina Soldo, Peter Hettegger, Istvan Gyurjan, Ronald Kulovics, Silvia Schönthaler, Gabriel Beikircher, Albert Kriegner, Stephan Pabinger, Klemens Vierlinger A90 Rare disease diobanks for personalized medicine Ayşe Yüzbaşıoğlu, Meral Özgüç, Member of EuroBioBank - European Network of DNA, Cell and Tissue Banks for Rare Disease

Magnesium diboride superconductor: thermal stabilization and doping

The primary aims of this research were to (i) improve the thermal stability of MgB2 wires, and (ii) investigate the effects of different doping materials on the electromagnetic behaviour of MgB2 in wire form, enabling practical application of this superconductor. In this work, a pioneering results on the fabrication of Al-stabilized Fe-clad MgB2 wires have been presented. First, the Al-stabilized Fe-clad MgB2 wires were fabricated using the existing powder in tube method. The possibility of low temperature in-situ MgB2 formation, as well as the compatibility of the Fe barrier layer and the Al stabilizer at increasing fabrication temperatures of Al/Fe-clad MgB2 wires have been demonstrated. The range of optimal temperatures (600 - 630oC) and time of sintering (180 - 30 min) for production of Al-stabilized Fe-clad MgB2 wires were empirically observed. The main limitations of this method are (i) reduced density of the superconducting core during drawing of relatively soft Al metal, and (ii) degraded connectivity between Al and Fe metals, so that they are not suitable for fabrication of long MgB2 wires. Thus, a new approach towards fabrication of Al-stabilized MgB2 wires (namely the hot aluminizing technique) was developed. In this technique, fully optimized and in-situ reacted Fe/MgB2 wire was immersed in a molten Al bath, resulting in a uniform Al coating of Fe-clad MgB2 wire. As demonstrated, this approach does not result in any degradation of superconducting properties ofinal Al-stabilized Fe-clad MgB2 wires. However, this enables reduction of the Fe barrier thickness and good connectivity between Fe and Al sheath materials. Furthermore, this approach is easily applicable for simultaneous aluminizing and in-situ formation of MgB2 wires, which can even be extended to fabrication of Al-stabilized Fe/MgB2 coils. Although realization of Al-stabilized MgB2 wires is shown to be possible, future work on stabilization should be focused on increasing the Al thickness, reduction of the Fe barrier layer, and demonstration of the stability effects on Al/MgB2 wires, which has not been investigated due to limitations of available equipment. Fe-based doping of MgB2 wires was studied in order to demonstrate the feasibility of introducing magnetic pinning sites into the MgB2 system, and to confirm the-oretical studies predicting improvement of current carrying ability of (ferro)magnet/ superconductor hybrid systems. A systematic study of doping materials, which included nano-Fe, home-made Fe2B, and SiO2 coated Fe2B nanoparticles, was conducted, and the effects of the above-mentioned Fe-based dopants on the su-perconducting properties of MgB2 wires were investigated. The SiO2 coated Fe2B nanoparticles were employed in order to study the feasibility of insulating the fer- romagnetic inclusions and superconducting matrix, as well as to enabling more ho- mogeneous distribution of ferromagnetic particles in MgB2 superconducting wires. The severe suppression of critical temperature (Tc), critical current density (Jc), and upper critical field (Bc2) was observed for all magnetic dopants studied with the most detrimental effect coming from nano-Fe doping and to a lesser extent - from SiO2 coated Fe2B nanoparticles. The degradation of superconducting prop- erties due to Fe-based dopants was attributed to an increased level of impurity phases in MgB2 compound, as confirmed by x-ray diffraction studies. Analysis of the electromagnetic properties suggested that the dominant pinning mechanism is the pinning on grain boundaries (as in pure MgB2 compound), and thus, magnetic pinning was not achieved in the samples studied by introduction of these Fe-based dopants. It is likely that more homogeneous systems (such as thin flms) are required in order to demonstrate the benefits of superconductor/ferromagnet interactions predicted by theoretical investigations. The effect of polymer C-based dopants on the properties of MgB2 wires was systematically investigated. Electromagnetic characteristics (Bc2(T) and Jc(Ba), where Ba is an applied magnetic field) of Fe-clad MgB2 wires with an optimal level of doping material were systematically improved with increasing sintering temperature. The ability of polymer dopants to dissolve in liquid media (water or toluene) and cover B particles by thin layer of amorphous carbon before MgB2 formation has significant benefits for the fabrication of Fe-clad MgB2-xCx wires with en- hanced homogeneity and electromagnetic performance. The analysis of structural and electromagnetic changes in the Fe-clad MgB2 wires doped with C2H6Si polymer and C12H22O11 materials revealed that more C (compared to nano-C doping) is incorporated into the MgB2 crystal lattice on B sites during sintering, resulting in (i) some reduction of critical temperature (by about 2 K), but (ii) formation of a larger number of nanoscale structural defects, favoring pinning of magnetic vortices and leading to significant enhancement of the superconducting properties of the final Fe-clad MgB2-xCx wires. However, the results of this work indicate an emerging necessity to improve the density of MgB2-xCx in the wires in order to reach the superconducting properties obtained in the bulk samples. Another crucial issue is to reduce the level of MgO impurities which is a native impurity formation in any in-situ fabricated MgB2 compounds, although this level may also be increased by introduction of O-containing compounds (e.g. C12H22O11). As a result, suppressed current carrying ability was observed in C12H22O11 -doped MgB2 wires compared to the critical current density, Jc(Ba), of MgB2 wires with addition of oxygen free C2H6Si doping material. This observation confirms that, in spite of imperfectly connected MgB2 grains, flowing current is notably affected by the increased level of insulating MgO impurities that preferentially form at the grain boundaries. Results obtained in this work indicate that oxygen free C2H6Si dopant is to be the most optimal and thus promising for practical application of MgB2-xCx wires

Identification of factors limiting the critical current density in MgB2 _xCx superconductors at low magnetic fields

Structural analysis and electromagnetic measurements have been performed on a range of samples prepared by the liquid mixing approach to doping MgB2 are sugar, malic acid, and polycarbosilane. The results obtained have allowed us to clarify the contributions of the factors limiting critical current at low magnetic fields in doped MgB2

Superconducting properties of Al-stabilized MgB2 wires

FeMgB2 wires have been prepared using an in situ technique and the standard PIT method. Short samples of FeMgB2 wire were sintered at 750 C for 30 min and then coated with Al by a hot aluminizing technique. Transport critical current was measured by the pulsed method with voltage contacts attached directly onto the Al surface. The transport Jc of AlFeMgB2 wires reached 3 104 A/cm2 at 10 K and 5 T and 104 A/cm2 at 20 K and 5 T. The influence of the Al stabilizer on thermomagnetic instabilities and superconducting properties in the FeMgB2 wires is investigated

Temperature effect on microstructure and electromagnetic performance of polycarbosilane and sugar-doped MgB2 wires

The effect of processing temperature on structural and superconducting properties of 10 wt.% sugar- and 10 wt.% PCS-doped MgB2 wires is systematically investigated. It is demonstrated that these dopants significantly enhance the electromagnetic performance of Fe-clad MgB2 superconductor and increase its potential for practical application. The enhancement of in-field critical current density (Jc(Ba)) and upper critical field (Bc2) is due to formation of a large amount of lattice defects caused by impurities and C substitution into the MgB2 crystal lattice. High temperature sintering of sugar-doped sample results in as high Bc2 value as 37 T (at 5 K), which correlates with higher level of C substitution into MgB2 crystal lattice in this sample. In contrast, for PCS doped MgB2 wire higher Bc2 value (32 T at 5 K) is observed at lower sintering temperatures. In spite of the fact that the level of C in the crystal lattice and Bc2 value are higher in the sugar doped MgB2 sample, this sample has lower Jc(Ba) when compared to the sample with PCS addition. We speculate that it is due to a higher level of MgO impurities in the sugar doped sample (18.6 wt.% compared to 9.15 wt.% in the PCS doped sample), which results in the dissipation of supercurrent flowing through this sample

Mapping Asia Plants: The brief historical overview of botanical studies in European Russia

European part of Russia covers ~1/3 of Europe, an area of approximately 3742,000 sq km. Systematic floristic research of this area began in the 19th century, with the first complete flora of European Russia by Fedchenko and Flerov (1908–1910), which contained 3542 species and many varieties. The most important modern source of floristic information on this territory are Flora partis Europaeae URSS (Tsvelev et al., 1974–1989) with Flora of Eastern Europe (Tsvelev, 1996–2004), which contain about 7300 species. The most important macroregional floristic reviews are “Flora Regionis Boreali-Orientalis Territoriae Europaeae URSS” (Tolmachev, 1974–1977), 11th edition “Flora…” of P. F. Mayevsky (2014) and “Flora of the Lower Volga region” (Skvortsov and Reshetnikova, 2006–2018, not finished). Among 46 regions (cities of Moscow, Sevastopol, and St.-Petersburg are excluded), 22 have high quality modern floristic reviews, 11 regions have average reviews, and 13 regions have low quality reviews; 13 regions have modern floristic reviews in preparation

Mapping Asia Plants: The brief historical overview of botanical studies in European Russia

European part of Russia covers similar to 1/3 of Europe, an area of approximately 3742,000 sq km. Systematic floristic research of this area began in the 19th century, with the first complete flora of European Russia by Fedchenko and Flerov (1908-1910), which contained 3542 spe -cies and many varieties. The most important modern source of floristic information on this territory are Flora partis Europaeae URSS (Tsvelev et al., 1974-1989) with Flora of Eastern Europe (Tsvelev, 1996-2004), which contain about 7300 species. The most important mac-roregional floristic reviews are Flora Regionis Boreali-Orientalis Territoriae Europaeae URSS (Tolmachev, 1974-1977), 11th edition Flora... of P. F. Mayevsky (2014) and Flora of the Lower Volga region (Skvortsov and Reshetnikova, 2006-2018, not finished). Among 46 re-gions (cities of Moscow, Sevastopol, and St.-Petersburg are excluded), 22 have high quality modern floristic reviews, 11 regions have average reviews, and 13 regions have low quality reviews; 13 regions have modern floristic reviews in preparation. (C) 2021 The Author(s). Published by Elsevier B.V. CC_BY_NC_ND_4.